Leaflet TELASSMO 80mg / 5mg tablets

Indicated for: hypertension

Route of administration: oral

Substance: telmisartan + amlodipine (angiotensin II receptor blocker + calcium channel blocker)

ATC: C09DB04 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers)

Precautions:
Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

This combination of telmisartan and amlodipine is used for the treatment of hypertension in patients requiring combination therapy to control blood pressure. Telmisartan is an angiotensin II receptor antagonist, while amlodipine is a calcium channel blocker that relaxes blood vessels.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as dizziness, edema, or headaches. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, edema, headaches, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about TELASSMO 80mg / 5mg

  • Substance: telmisartan + amlodipine
  • Date of latest medicines list: 16-08-2017
  • Product code: W63587001
  • Concentration: 80mg / 5mg
  • Pharmaceutical form: tablets
  • Quantity: 14
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 14418/2022/01
  • Shelf life: 18 months

Concentrations available for telmisartan + amlodipine

  • 40mg/10mg
  • 40mg/5mg
  • 80mg/10mg
  • 80mg/5mg